AtaiBeckley (ATAI) Current Deferred Revenue (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly Current Deferred Revenue of $1.5 million in Q1 2026, down 2.89% quarter-over-quarter from $1.5 million in Q4 2025, and down 1.33% on a YoY basis from $1.5 million in Q1 2025.
AtaiBeckley (ATAI) Current Deferred Revenue (2021 - 2026) Analysis & Trends
AtaiBeckley has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $575000.0 for Q3 2025.
- In Q1 2026, Current Deferred Revenue fell 1.33% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 1.33% YoY), while the FY2025 annual figure was $1.5 million, up 111.37% from the prior year.
- Current Deferred Revenue was $1.5 million for Q1 2026 at AtaiBeckley, down from $1.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.5 million in Q4 2025 to a low of $721000.0 in Q4 2024.
- Historically, Current Deferred Revenue has averaged $1.3 million across 3 years, with a median of $1.5 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue soared 111.37% in 2025, then retreated 1.33% in 2026.
- A 3-year view of Current Deferred Revenue shows it stood at $721000.0 in 2024, then jumped by 111.37% to $1.5 million in 2025, then retreated by 2.89% to $1.5 million in 2026.
- The last three Current Deferred Revenue figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 575,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 721,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 120,000.00 |